Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71914712 | 7191471 | 2 | F | 2008 | 20130515 | 20091127 | 20130930 | PER | US-AMGEN-KDL361840 | AMGEN | 65.00 | YR | F | Y | 0.00000 | 20130930 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71914712 | 7191471 | 1 | PS | Enbrel | 1 | SUBCUTANEOUS | 50 MG, QWK | U | 1009209 | 103795 | 50 | MG | UNKNOWN FORMULATION | /wk | |||||
| 71914712 | 7191471 | 2 | SS | Enbrel | 1 | U | 103795 | UNKNOWN FORMULATION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 71914712 | 7191471 | 1 | Psoriasis |
| 71914712 | 7191471 | 2 | Psoriatic arthropathy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 71914712 | 7191471 | Injection site irritation | |
| 71914712 | 7191471 | Injection site pain | |
| 71914712 | 7191471 | Injection site rash | |
| 71914712 | 7191471 | Psoriasis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 71914712 | 7191471 | 1 | 20090701 | 0 |